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Abstract 
Purpose: To develop an easy, fast and sensible spectrophotometric method for determination of 
tofisopam in tablet dosage form.   
Methods: Tofisopam as n-electron donor is react with two π-acceptors namely: chloranilic acid (ChA), 
and 7,7,8,8 tetracyanoquinodimethane (TCNQ) to form charge-transfer complexes. The obtained 
complexes were tested spectrophotometrically at 520 and 824 nm for ChA and TCNQ, respectively. The 
optimal conditions affecting the reaction status were surveyed and optimized, and the results compared 
with Japanese Pharmacopeia method. 
Results: The calibration curve were obeyed Beer`s low in the ranges 25 – 125 and 30 – 150 µg/mL for 
ChA and TCNQ, respectively. The lower limit of detection was 8.0 and 10.0 µg/m for ChA and TCNQ, 
respectively.  The slope and intercept of the calibration graphs were 0.0025 and 0.011, and 0.0115    
and -0.237 for ChA and TCNQ, respectively    
Conclusion: The proposed methods have successfully been applied to determination of tofisopam with 
good accuracy and precision. The methods are accurate as the Japanese pharmacopeial method amd 
may be applied for routine analysis in quality control laboratories. 
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Tofisopam is a 1, 2-benzodiazepine and is 
analogous with other anxiolytic benzodiazepines 
which are generally 1,4- or 1,5-substituted. 
However, tofisopam does not have 
anticonvulsant, calming [1], skeletal reduce 
tension, motor skill-damaging or amnestic [2] 
features (Figure 1) [3]. Tofisopam is used for the 
therapy of worry and alcohol retraction, and is 
prescribed in a dose of 50 - 300 mg daily, 
separated into three doses. Tofisopam is not 
reported to cause dependence to the same 
extent as other benzodiazepines, but is advised 
to be prescribed for a maximum of 12 weeks. 
 
Tofisopam is a PDE10A inhibitor, is said to be a 
beneficial therapy for mental disorder (4). The 
pharmacological effectiveness of tofisopam 
(TOF) and its inherent toxicity have encouraged 
efforts aimed at the development of different 
assay methods for the drug. 
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Figure 1: Chemical structure of tofisopam 
 
Spectrophotometry [5,6], spectrofluorometry 
[5,7], high performance liquid chromatography 
(HPLC) using either reverse-phase 
chromatography [8-10] or enantiomeric   
separation [11,12], gas chromatography (GC) 
[13,14], and super critical chromatography [15] 
have been cited in the literature for the 
determination of tofisopam in its dosage form.  
Although, most of these methods are sensitive, 
however, they include much time, derivatization 
procedure, high price that are not obtainable in 
most quality control laboratories. 
  
However, only two spectrophotometric methods 
have been reported [5,6]. The first method is 
based on reduction of ferric into ferrous in the 
presence of 1,10-phenanthroline to give an 
orange-red colored ferroin complex that absorbs 
at 510 nm [5], while the second method is based 
on derivative technique [6]. 
 
Charge-transfer complexes [16,17] are based on 
the interaction between electron donors and 
acceptors, which are characterized by absorption 
of radiation in ultra-violet and visible regions (200 
- 800 nm).  Compounds of n-electron donor react 
rapidly with π- acceptors and lead to form a fast 
complex at normal conditions. Π-Acceptors are 
used for the development and establishment of 
spectrophotometric methods for the 
determination of–n-electron donor compounds, 
especially biologically active pharmaceutical 
compounds. The aim of the present study was to 
investigate the charge transfer reaction between 
n-donor (tofisopam) with π- acceptor (ChA and 
TCNQ) to form a charge-transfer complex for 






A  Shimadzu UV-1800 double-beam ultraviolet-
visible spectrophotometer with 1-cm quartz cells 
was used. 
 
Materials and reagents 
 
Chloranilic acid (ChA), purchased from Merck, 
Darmstadt, Munich, Germany.  A 1 mg/mL 
solution of chloranilic acid was prepared in 
acetonitrile. 7, 7, 8, 8-Tetracyanoquinodimethane 
was obtained from Aldrich Chemical Co., 
Milwaukee, USA; its solution (1 mg/mL) was 
prepared in acetonitrile. All reagent solutions 
were stable for at least 1 week when kept in a 
refrigerator. Pure tofisopam (≥ 98 %) was 
purchased from Sigma (St Louis, Mo, USA). 
Stock solution of tofisopam (500 µg/mL) was 
prepared by dissolving the exact amount of 
tofisopam in acetonitrile. Suitable working 
solutions were prepared by suitable dilution of 
the stock solution in acetonitrile. Acetonitrile was 
of analytical reagent grade. Nodeprine tablets 
was obtained from Acapi Pharmaceuticals, Cairo, 
Egypt, and each contained 50 mg of tofisopam. 
 
Determination of tofisopam in its dosage 
form 
 
Ten tablets were weighed accurately and ground 
well. A quantity of the powder equivalent to 50 
mg of TOF was transferred into 100 mL 
measuring flask and dissolved in acetonitrile in 
an ultrasonic bath for about 40 min. The solution 
was filtered through Whatman filter paper no. 41, 
then the filtrate was transfer into a 100 mL 
volumetric flask and diluted to the mark with 
acetonitrile.  Another appropriate aliquot of this 
solution was transferred into 10 mL volumetric 
flask, then the unknown concentration of the drug 





An appropriate amount of the standard solution 
of tofisopam covering the calibration graph    was 
transferred into a 10 ml calibrated flasks, then 
one mL of ChA reagent was added.  Complete 
the flask with acetonitrile and read the 
absorbance at 520 nm. In case of TCNQ, An 
appropriate amount of sample solution of 
tofisopam covering the calibration graph   was 
transfer into test tube, 1 mL of TCNQ reagent 
was added, then   heated at 70 oC for 20 min in 
water bath. The resulting solution was cool down, 
then transfer into 10-ml measuring flask and 
completed to the mark with acetonitrile. The 
absorbance of the outcome solutions was 
measured at the 842 nm.  The calibration curve 
for each reagent was prepared by plotting 
absorbance versus concentration of tofisopam. 
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Validation of the proposed method 
 
Under the optimum reaction situations, the 
calibration curves for tofisopam were developed 
by prepared an appropriate concentration range 
of the drug with each reagent. Each 
concentration was tested five times and the 
average absorbance was estimated, then plotted 
against concentration.   Regression equations of 





Tofisopam is a nitrogenous compound that act as 
n-donor which react with π-acceptors e.g. 
chloranilic acid (ChA) and 7, 7, 8, 8 
tetracyanoquinodimethane (TCNQ) to form 
charge transfer complex. The resulting 
complexes  exhibit an absorption maximum at 
520 nm with ChA, instantaneously  while the 
other complex exhibit a maximum absorbance at 
841 nm (TCNQ) after heating at 70 oC for about 
20 min. In case of ChA, the purple color 
instantaneously is formed at room temperature. 
On the other hand, the producing complex with 
TCNQ reagent exhibit a blue color was formed 
when heated at 70 oC for about 20 min.  One ml 
of TTCNQ solution was found to be suitable for 
production of maximum absorbance. The 
intensity of the product color remains stable for 
about 1 h. 
 
Effect of reagent concentration 
 
Varying reagent concentrations (1 mg/mL, 
acceptors) were added to a constant 
concentration of tofisopam, but it was noticed 
that 1.0 mL each of ChA and TCNQ, 
respectively, was adequate for the production of 
maximum absorbance. Larger amounts of the 
reagents did not influence absorbance. Figure 2 
shows the absorption curves of the drug with 
ChA and TCNQ reagents. As a result, 1 ml of 
reagent was used in all the tests.  
 
Effect of reaction time and temperature 
 
The optimum reaction time was monitored at by 
measuring the absorbance at 520 nm for ChA at 
room temperature (25 oC).  Color was developed 
instantaneously and the intensity of the resulting 
color did not change over time. The color 
produced was stable for about 1 h.  On the other 
hand, TCNQ formed an intense chromogen with 
tofisopam when heated at 70 oC for 20 min.  
However, at room temperature, only a faint color 
appeared and the absorbance of the color 
increased with increase in time. The 
development of maximum color intensity was 
achieved when heated at 70 oC for about 20 min.  
 
Stoichiometry of the reaction 
 
To determine the molar ratio between the drug 
(n-donor) and the reagent (π- acceptors), Job’s 
method [18] of continuous variation was 
employed. Two master equimolar (2.83 × 10-4 M) 
solutions of TOF and ChA or TTCNQ were 
prepared.  Different series of the master 
solutions of TOF and ChA as well as TOF and 
TCNQ, were made up in varying ratios (1:9, 2:8, 
3:7, etc… and 9:1). The solutions were further 
measured as described above.  The molar ratio 
of the reactants (drug: reagent) was determined 
by continuous variation method (Job’s method) 
[18] to a form charge-transfer complex. As shown 




Figure 2: Absorption spectrum of tofisopam (50 µg/ml) with (A) ChA and (B) TCNQ reagents as π-acceptor 
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Figure 3:  Continuous variation plot of tofisopam: (A) 
TOF: ChA and (B) TOF: TCNQ 
 
Effect of diluting solvent 
 
The charge transfer reaction was carried out in 
different solvents, including acetonitrile, acetone, 
ethanol, water, DMF and DMSO, in order to 
optimize the most suitable medium for the 
reaction. Acetonitrile proved to be the most 
suitable dilution solvent because it afforded 
superior solvating power for ChA and TCNQ 
reagents and gave high absorbance intensity.  
Acetonitrile was considered as an ideal solvent 
for the charge transfer reaction offering 
maximum sensitivity, due to its high dielectric 
constant which raised maximum yield of radical 
anions, and high solvation power for the 
acceptors [19]. 
   
Validity of the proposed method 
 
Limit of quantification (LOQ) and of detection 
(LOD) 
 
A calibration graph was linear over the 
concentration range of 25 – 120 ppm and 30 – 
150 ppm for ChA and TCNQ, respectively.  
Lower limit of quantification (LOQ) and lower limit 
of detection (LOD) are presented in Table 1. The 
least square equation extracted from the 
calibration graph is presented in the following 
equation:    y = ax ± b, where y is the 
absorbance, a slope, x concentration, the exact 
equation is y =0.0025x+ 0.0115 and y =0.011x -
0.12373) for ChA and TCNQ, respectively.  
where y, a,  x  and r  are the absorbance,  x: 
concentration of TOF  and  a: is the slope ,  b : is 
the intercept and r is correlation coefficient 
(0.998 and 0.997 for ChA and TCNQ), 
respectively. The lower limit of detection (LOD) 
and quantification (LOQ) were estimated (21) 
using the formula: LOD or LOQ = K. SD. b/a 
where K= 3.3 for LOD and 10 for LOQ, SD b is 
the standard deviation of the intercept, and a is 
the slope. The lower limit of quantification was 
found to be 25.0 and 30.0 ppm while the lower 
limit of detection was 8.0 and 10.0 ppm for ChA 
and TCNQ respectively. The correlation 
coefficient was 0.998 and 0.997 for ChA and 
TCNQ, respectively.  
 
Table 1: Quantification parameters for the analysis of 
tofisopam by the proposed method 
 
Parameter ChA TCNQ 
Beer`s law limits, µg/mL 25-125 30-150 
Slope (b) 0.0025 0.011 
Intercept (a) 0.0115 -0.2373 
Correlation coefficient, (r2) 0.998 0.997 
Lower limit of quantification  
(LOQ, µg/mL) 
25.0 30.0 
Lower limit of detection 
 (LOD, µg/mL) 
8.0 10.0 
Standard deviation of residual XY 0.0096 0.064 
* A = a   b, where a = slope, b= intercept and  = 




In order to investigate the effect of commonly 
encountered compounds that are present in 
tofisopam dosage form, interference studies 
were carried out. Tablet excipients such as 
starch, lactose and glucose had a negligible 
effect on the determination of tofisopam. Thus, 
the proposed method can be applied for 
determination of tofisopam in the dosage form 
without interferences from the excipients.  The 
results in Table 3, show a mean range of 96.8 - 
99.6 and 96.6 - 98.6 % for ChA and TCNQ, 
respectively, indicating that there was no 
interference from the excipients present in the 
dosage form. 
 
Precision and accuracy of the method 
 
Intra-day and inter-day accuracy and  precision 
of the developed method were investigated  The 
accuracy and precision were and carried out by 
the analysis of tofisopam using six replicates 
during the day and on different days in the limit of 
quantification range. Precision and accuracy of 
the proposed method are expressed as RSD (%) 
and recovery (%), respectively. The results in 
Table 2 are within the acceptance range.  Intra-
day and inter-day precision were 2.7 - 3.0 and 
2.6 - 2.9 %, and 2.7 - 3.2 and 2.5 - 3.0 % for 
TOF-ChA and TOF-TCNQ, respectively. On the 
other hand, the accuracy of the method for intra- 
and inter-day were in the range 96.3 - 99.0 and 
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The analysis of tofisopam using two different 
analyst (operator) and different devices in 
different days were carried out to evaluate the 
ruggedness of the suggested spectrophotometric 
method. Results of the relative standard 
deviation was < 3.3 %, after repetitive 
measurements over three days and over an 
entire day, using two different instruments and 
two operators, This indicates that the proposed 




The optimum experimental factors that influence 
the absorbance was examined in order to 
evaluate the robustness of the proposed method. 
RSD was < 3.3 % under different conditions. The 
studied parameters were reagent concentration, 
reaction time, and stability of the resulting 
complex.  These results indicate that the 
proposed method is fairly robust.  
 
Application of the proposed method 
 
The assay of the drug in a dosage form was first 
assessed for determination of tofisopam in pure 
solution to test the reliability of the method. 
Determination of tofisopam by proposed 
spectrophotometric method gave 96.8 - 99.0 and 
96.6 - 98.6 % with RSD of 2.4 - 2.8 and 2.5 - 2.8 
% for TOF-ChA and TOF-TCNQ, respectively 
(Table 3). These results show that the method 
has good accuracy and can be applied for 
determination of the drug in the dosage form. 
 
Table 4 shows he results obtained for the 
determination of tofisopam in its dosage form 
using the proposed spectrophotometric method 
and compared with the official titrimetric method 
from Japanese Pharmacopeia [20]. The obtained 
data obtained by both methods are comparable. 
 
Table 2: Intra- and inter-day results for the proposed method 
 




R (%) RSD (%) Error (%) 




29.1 ± 0.87 
49.0 ± 1.37 














39.1 ± 1.13 
79.1 ± 2.136 














28.9 ± 0.92 
48.8 ± 1.42 


























*n = 5 
 
Table 3:  Validation of the proposed method for the determination of tofisopam 
  










24.2 ± 0.68 
49.0 ± 1.27 
74.0 ± 1.85 
99.1 ±  2.38 





















29. 0 ± 0.81 
49.1 ± 1.28 
79.2 ± 2.06 
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Table 4: Determination of tofisopam in tablet using the suggested methods and the official titrimetric method 
 
Parameter ChA DCNQ Official method * 
Label claim, 50 
mg/tablet   





The formation of charge transfer complex due to 
the interaction of n-electron donner (tofisopam) 
with π-acceptors (ChA, and TCNQ) which 
produced a colored charge transfer complex with 
low molar absorptivity in non-polar solvent. In 
contrast, in polar solvents such as acetonitrile, a  
full electron transfer from tofisopam (D), (n 
electron donor), to the acceptor moiety (A) (π-
acceptors, in this case ChA and TCNQ)  took  
place with the production  of strong colored 
radical ions with high molar absorptivity,    
according to Eq 1.  
 
D + A      ⇄    (D-A)    ⇄   D.+  +  A.- ……. (1) 
                    complex       radicals  ions 
 
The separation of the donor-acceptor complex 
(D-A) was confirmed by the high degree of 
ionizing power of the polar solvent, acetonitrile 
[21]. The apparent color complex has different 
absorption maxima at 520 and 842 nm for ChA 
and TCNQ, respectively. The color species 
produced with TCNQ in acetonitrile is a bluish-
green colored radical anion, showing a strong 
absorption maxima at three different wavelengths 
742, 825 and 842 nm. These bands indicate the 
formation of the radical anion, TCNQ •-, which 
perhaps is formed by the separation of an 
original (donor-acceptor) complex (D-A) between 




A spectrophotometric method for the assay of 
tofisopam in its dosage form has been 
developed. The method is based on using ChA 
and TCNQ as π-acceptors. The validated 
method compares well with the official titrimetric 
method.  The developed method is simple, 
economical, rapid, accurate, sensitive and should 
be suitable for routine quality control of tofisopam 
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